184 related articles for article (PubMed ID: 32816275)
21. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
23. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy.
Schneider J; Gonzalez-Roces S; Pollán M; Lucas R; Tejerina A; Martin M; Alba A
Breast Cancer Res; 2001; 3(3):183-91. PubMed ID: 11305953
[TBL] [Abstract][Full Text] [Related]
24. Multidisciplinary approach to breast cancer diagnosed during pregnancy: maternal and neonatal outcomes.
Córdoba O; Llurba E; Saura C; Rubio I; Ferrer Q; Cortés J; Xercavins J
Breast; 2013 Aug; 22(4):515-9. PubMed ID: 23116970
[TBL] [Abstract][Full Text] [Related]
25. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of pregnancy-associated breast cancer].
Tajti J; Pieler J; Simonka Z; Paszt A; Lázár G
Magy Seb; 2014 Aug; 67(4):268-70. PubMed ID: 25123803
[TBL] [Abstract][Full Text] [Related]
27. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
Michieletto S; Saibene T; Evangelista L; Barbazza F; Grigoletto R; Rossi G; Ghiotto C; Bozza F
Breast; 2014 Feb; 23(1):19-25. PubMed ID: 24189101
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of pregnancy associated breast cancer.
Rosenkranz KM; Lucci A
Breast Dis; 2005-2006; 23():87-93. PubMed ID: 16823171
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer in pregnancy.
Rovera F; Frattini F; Coglitore A; Marelli M; Rausei S; Dionigi G; Boni L; Dionigi R
Breast J; 2010; 16 Suppl 1():S22-5. PubMed ID: 21050304
[TBL] [Abstract][Full Text] [Related]
30. Lessons learned from an unusual case of inflammatory breast cancer.
Harrison AM; Zendejas B; Ali SM; Scow JS; Farley DR
J Surg Educ; 2012; 69(3):350-4. PubMed ID: 22483137
[TBL] [Abstract][Full Text] [Related]
31. Contemporary operative management of T4 breast cancer.
Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Carter JM; Glazebrook KN; Hieken TJ
Surgery; 2016 Oct; 160(4):1059-1069. PubMed ID: 27521042
[TBL] [Abstract][Full Text] [Related]
32. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
Yagata H; Kajiura Y; Yamauchi H
Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
34. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
35. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
[TBL] [Abstract][Full Text] [Related]
36. ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.
Li JW; Mo M; Yu KD; Chen CM; Hu Z; Hou YF; Di GH; Wu J; Shen ZZ; Shao ZM; Liu GY
PLoS One; 2014; 9(12):e114646. PubMed ID: 25504233
[TBL] [Abstract][Full Text] [Related]
37. Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy.
Agrawal G; Chen JH; Baick CH; Chen AE; Mehta RS; Nalcioglu O; Su MY
J Clin Oncol; 2007 Jun; 25(18):2618-20. PubMed ID: 17577043
[No Abstract] [Full Text] [Related]
38. Tailoring Treatment for Patients with Inflammatory Breast Cancer.
Newman AB; Lynce F
Curr Treat Options Oncol; 2023 Jun; 24(6):580-593. PubMed ID: 37043118
[TBL] [Abstract][Full Text] [Related]
39. Treatment of breast cancer in countries with limited resources.
Carlson RW; Anderson BO; Chopra R; Eniu AE; Jakesz R; Love RR; Masetti R; Schwartsmann G;
Breast J; 2003; 9 Suppl 2():S67-74. PubMed ID: 12713499
[TBL] [Abstract][Full Text] [Related]
40. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
